Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. Keeping that in mind, here are three profitable companies to avoid and some better opportunities instead.

Nature's Sunshine (NATR)

Trailing 12-Month GAAP Operating Margin: 5.7%

Started on a kitchen table in Utah, Nature’s Sunshine (NASDAQ: NATR) manufactures and sells nutritional and personal care products.

Why Does NATR Worry Us?

1. Annual revenue growth of 5.3% over the last three years was below our standards for the consumer staples sector
2. Revenue base of $489.8 million puts it at a disadvantage compared to larger competitors exhibiting economies of scale
3. Operating margin of 5.3% falls short of the industry average, and the smaller profit dollars make it harder to react to unexpected market developments

Nature's Sunshine is trading at $21.08 per share, or 17.2x forward P/E. To fully understand why you should be careful with NATR, check out our full research report (it’s free).

Delta (DAL)

Trailing 12-Month GAAP Operating Margin: 8.1%

One of the ‘Big Four’ airlines in the US, Delta Air Lines (NYSE: DAL) is a major global air carrier that serves both business and leisure travelers through its domestic and international flights.

Why Are We Out on DAL?

1. Sluggish trends in its revenue passenger miles suggest customers aren’t adopting its solutions as quickly as the company hoped
2. Free cash flow margin is expected to remain in place over the coming year
3. Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results

At $86.36 per share, Delta trades at 10.2x forward P/E. Dive into our free research report to see why there are better opportunities than DAL.

Henry Schein (HSIC)

Trailing 12-Month GAAP Operating Margin: 4.9%

With a vast inventory of over 300,000 products stocked in distribution centers spanning more than 5.3 million square feet worldwide, Henry Schein (NASDAQ: HSIC) is a global distributor of healthcare products and services primarily to dental practices, medical offices, and other healthcare facilities.

Why Are We Hesitant About HSIC?

1. Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
2. Estimated sales growth of 3.7% for the next 12 months is soft and implies weaker demand
3. Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability

Henry Schein’s stock price of $88.27 implies a valuation ratio of 16x forward P/E. If you’re considering HSIC for your portfolio, see our FREE research report to learn more.

High-Quality Stocks for All Market Conditions

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.